Research and Markets: Global Erectile Dysfunction Pipeline Capsule – 2013

Posted: Published on June 13th, 2013

This post was added by Dr P. Richardson

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/t224qj/global_erectile) has announced the addition of the "Global Erectile Dysfunction Pipeline Capsule - 2013" report to their offering.

Fore Pharma's latest report Global Erectile Dysfunction Pipeline Capsule - 2013' provides up-to-date information on key Research and Development (R&D) activities in the global erectile dysfunction market. It covers active erectile dysfunction pipeline molecules in clinical trials, preclinical research, and drug discovery.

This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

The scope of the report includes information on erectile dysfunction pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Erectile dysfunction pipeline molecules licensing activities are also covered in this report.

Key Topics Covered

1. Erectile Dysfunction - Disease Overview

2. Erectile Dysfunction Pipeline Overview

3. Erectile Dysfunction Pipeline by Geography

4. Erectile Dysfunction Phase 3 Clinical Trial Pipeline Insights

See the rest here:
Research and Markets: Global Erectile Dysfunction Pipeline Capsule - 2013

Related Posts
This entry was posted in Erectile Dysfunction. Bookmark the permalink.

Comments are closed.